Loading...
•
Mar 31, 2021
Globus Medical Q1 2021 Earnings Report
Globus Medical's Q1 2021 financial performance was announced, demonstrating substantial growth in net sales and net income.
Key Takeaways
Globus Medical reported a strong start to 2021 with a 19.3% increase in worldwide net sales, reaching $227.3 million. GAAP net income increased by 74.7% to $45.3 million, and non-GAAP adjusted EBITDA reached $81.0 million, marking 35.2% of net sales.
Worldwide net sales increased by 19.3% compared to Q1 2020, totaling $227.3 million.
GAAP net income rose by 74.7% to $45.3 million, representing 19.9% of net sales.
GAAP diluted EPS was $0.44, and non-GAAP diluted EPS was $0.49.
Non-GAAP adjusted EBITDA was $81.0 million, accounting for 35.2% of net sales.
Revenue by Segment
Revenue by Geographic Location
Forward Guidance
The company increased full year 2021 net sales guidance from $880 million to $925 million and non-GAAP diluted earnings per share guidance from $1.83 to $1.89.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...